| 1 |
34113218 | Early Changes in [18F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts. | 2021 |
1 |
| 2 |
27920093 | Metformin reduces glycometabolism of papillary thyroid carcinoma in vitro and in vivo. | 2017 Jan |
1 |
| 3 |
27666620 | The correlation between FDG uptake and biological molecular markers in pancreatic cancer patients. | 2016 Oct |
4 |
| 4 |
26178426 | Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications. | 2015 Nov 1 |
1 |
| 5 |
19349386 | Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis. | 2009 Sep |
1 |
| 6 |
19837761 | Downregulation of 18F-FDG uptake in PET as an early pharmacodynamic effect in treatment of non-small cell lung cancer with the mTOR inhibitor everolimus. | 2009 Nov |
1 |
| 7 |
16341243 | Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. | 2006 Jan |
2 |